MD3593788T2 - Compoziții oftalmice care conțin un azot care eliberează prostamidă - Google Patents

Compoziții oftalmice care conțin un azot care eliberează prostamidă

Info

Publication number
MD3593788T2
MD3593788T2 MDE20200084T MDE20200084T MD3593788T2 MD 3593788 T2 MD3593788 T2 MD 3593788T2 MD E20200084 T MDE20200084 T MD E20200084T MD E20200084 T MDE20200084 T MD E20200084T MD 3593788 T2 MD3593788 T2 MD 3593788T2
Authority
MD
Moldova
Prior art keywords
prostamide
ophthalmic compositions
compositions containing
nitric oxide
oxide releasing
Prior art date
Application number
MDE20200084T
Other languages
English (en)
Inventor
Frederic Pilotaz
Alan L Weiner
Marina Do
Julien Saldo
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of MD3593788T2 publication Critical patent/MD3593788T2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Prezenta invenţie furnizează compoziţii oftalmice apoase în formă de soluţii care cuprind ester 6-(nitrooxi)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(etil-amino)-7-oxo-2-hepten-1-il]-3,5-dihidroxiciclopentil]-1-(2-feniletil)-2-propen-1-ilic al acidului hexanoic si hidroxistearat de macrogol 15 ca singurul agent de solubilizare si o metoda de preparare a acestora.
MDE20200084T 2018-07-12 2019-07-10 Compoziții oftalmice care conțin un azot care eliberează prostamidă MD3593788T2 (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18290082 2018-07-12

Publications (1)

Publication Number Publication Date
MD3593788T2 true MD3593788T2 (ro) 2021-03-31

Family

ID=63012964

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20200084T MD3593788T2 (ro) 2018-07-12 2019-07-10 Compoziții oftalmice care conțin un azot care eliberează prostamidă

Country Status (26)

Country Link
US (4) US10688073B2 (ro)
EP (2) EP3718535A1 (ro)
JP (4) JP6672512B2 (ro)
KR (1) KR20210032435A (ro)
CN (2) CN111249228B (ro)
AR (1) AR115734A1 (ro)
AU (1) AU2019300203A1 (ro)
BR (1) BR112021000240A2 (ro)
CA (1) CA3105989A1 (ro)
CY (1) CY1123706T1 (ro)
DK (1) DK3593788T3 (ro)
ES (1) ES2847853T3 (ro)
HR (1) HRP20210138T1 (ro)
HU (1) HUE052747T2 (ro)
LT (1) LT3593788T (ro)
MA (2) MA52258A (ro)
MD (1) MD3593788T2 (ro)
MX (2) MX2021000411A (ro)
PH (1) PH12020552112A1 (ro)
PL (1) PL3593788T3 (ro)
PT (1) PT3593788T (ro)
RS (1) RS61348B1 (ro)
SG (1) SG11202100064WA (ro)
SI (1) SI3593788T1 (ro)
TW (1) TWI839364B (ro)
WO (1) WO2020011845A1 (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6672512B2 (ja) * 2018-07-12 2020-03-25 ニコックス エス．エー． 一酸化窒素放出プロスタミドを含有する眼科用組成物
WO2023041182A1 (en) 2021-09-20 2023-03-23 Nicox Sa Nitric oxide releasing prostamide as neuroprotective agent

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918891B1 (fr) * 2007-07-20 2009-09-25 Thea Sa Lab Solution ophtalmique a base de prostaglandines sans conservateur
CA2702478C (en) * 2007-10-16 2014-12-09 Sun Pharma Advanced Research Company Limited Ophthalmic composition
AR076731A1 (es) * 2008-05-09 2011-07-06 Pfizer Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas
EP2334285A1 (en) 2008-09-12 2011-06-22 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
CN102970973A (zh) * 2010-05-07 2013-03-13 太阳医药高级研发有限公司 新型眼用组合物
FR2961694B1 (fr) 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
JP2014522849A (ja) * 2011-06-29 2014-09-08 アラーガン インコーポレイテッド ヒドロキシステアリン酸マクロゴール１５製剤
WO2013017821A1 (en) 2011-08-02 2013-02-07 Cipla Limited Pharmaceutical composition comprising ebastine and fluticasone
CN105012231A (zh) * 2014-04-30 2015-11-04 四川科伦药物研究院有限公司 一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法
CN105380901B (zh) * 2015-11-18 2018-07-17 侯宇华 一种他氟前列素滴眼剂及其制备方法
JP6672512B2 (ja) * 2018-07-12 2020-03-25 ニコックス エス．エー． 一酸化窒素放出プロスタミドを含有する眼科用組成物

Also Published As

Publication number Publication date
HUE052747T2 (hu) 2021-05-28
PL3593788T3 (pl) 2021-05-31
ES2847853T3 (es) 2021-08-04
WO2020011845A1 (en) 2020-01-16
JP2022116147A (ja) 2022-08-09
SG11202100064WA (en) 2021-02-25
CN110237031A (zh) 2019-09-17
JP7080268B2 (ja) 2022-06-03
RS61348B1 (sr) 2021-02-26
US20200016108A1 (en) 2020-01-16
US10688073B2 (en) 2020-06-23
JP2020105201A (ja) 2020-07-09
EP3593788A1 (en) 2020-01-15
LT3593788T (lt) 2021-04-12
US20210128458A1 (en) 2021-05-06
CY1123706T1 (el) 2022-05-27
EP3593788B1 (en) 2020-10-28
MA52258A (fr) 2021-02-17
US11020368B2 (en) 2021-06-01
MX2023007091A (es) 2023-06-27
SI3593788T1 (sl) 2021-03-31
CN111249228B (zh) 2022-05-03
MX2021000411A (es) 2021-03-25
JP2020011955A (ja) 2020-01-23
BR112021000240A2 (pt) 2021-04-06
DK3593788T3 (da) 2021-01-11
MA48919A (fr) 2020-01-15
JP2024023498A (ja) 2024-02-21
CA3105989A1 (en) 2020-01-16
JP6672512B2 (ja) 2020-03-25
TWI839364B (zh) 2024-04-21
PH12020552112A1 (en) 2021-05-31
EP3718535A1 (en) 2020-10-07
AR115734A1 (es) 2021-02-17
US20200206176A1 (en) 2020-07-02
PT3593788T (pt) 2021-01-21
CN110237031B (zh) 2022-02-11
CN111249228A (zh) 2020-06-09
HRP20210138T1 (hr) 2021-03-19
KR20210032435A (ko) 2021-03-24
AU2019300203A1 (en) 2021-03-04
MA48919B1 (fr) 2021-02-26
JP7397910B2 (ja) 2023-12-13
US20210220316A1 (en) 2021-07-22
TW202019401A (zh) 2020-06-01

Similar Documents

Publication Publication Date Title
DOP2020000023A (es) Nuevos derivados de quinolina
UY37480A (es) Nuevos derivados de quinolina
CU20190015A7 (es) Formulaciones de anticuerpos inhibidores de masp-2 altamente concentrados, de baja viscosidad y composiciones farmacéuticas que las comprenden
MA51204B1 (fr) Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
WO2015070224A3 (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
MA42561A (fr) Procédés de formulation de compositions de conjugués anticorps-médicament
CL2019003892A1 (es) Nuevos derivados de azaquinolina.
NZ746271A (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
MD3593788T2 (ro) Compoziții oftalmice care conțin un azot care eliberează prostamidă
EA201492290A1 (ru) Составы и способы для вагинальной доставки антипрогестинов
CL2020002252A1 (es) Formulación oftálmica.
EA201590730A1 (ru) Способ и стероидная композиция для местного применения
CL2020002891A1 (es) Nuevos derivados de quinolina
UY37971A (es) Derivados de indol macrocíclicos sustituidos
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
MA38679A1 (fr) Modulateurs du récepteur de cxcr7
EA201990560A1 (ru) Композиции, содержащие тритерпеноиды, и их применение для лечения оптической нейропатии
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
AR092691A1 (es) Composicion farmaceutica que comprende rebamipida
EA201690302A1 (ru) Композиции для местного применения для лечения избыточного потоотделения и способы их применения
CU24543B1 (es) Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias
EA201990550A1 (ru) Офтальмологический препарат, включающий азоловое соединение
MX2021005390A (es) Ingredientes farmaceuticos activos amorfos novedosos que comprenden carbonato de magnesio mesoporoso sustancialmente amorfo.
MA50116B2 (fr) Agent d'absorption transdermique comprenant du donépézil pour le traitement de la démence